H2 antagonists

3137 WPI Pill - white capsule-shape, 18mm

Pill with imprint 3137 WPI is White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of GERD; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Stomach Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Nizatidine (Nizatidine [ ni-za-ti-deen ])-3137 WPI-150 mg-White-Capsule-shape
Nizatidine (Nizatidine [ ni-za-ti-deen ])-3137 WPI-150 mg-White-Capsule-shape

Nizatidine
Generic Name: nizatidine [ ni-za-ti-deen ]
Imprint: 3137 WPI
Strength: 150 mg
Color: White
Size: 18.00 mm
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: H2 antagonists
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00591-3137
Inactive Ingredients: Silicon dioxide, Corn starch, Croscarmellose sodium, Magnesium stearate, Ammonia, Ferrosoferric oxide, Gelatin, Potassium hydroxide, Propylene glycol, Shellac, Sodium lauryl sulfate, Titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6,
Latest News
Related Drugs